Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial
Wolfgang Wick(Hertie Institute for Clinical Brain Research), Tobias Keßler(German Cancer Research Center)
Cited by 9
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
|The Lancet Oncology|2017|1.1k
Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells
|Brain|2005|78
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib
|Clinical Cancer Research|2018|77
BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells
|Cell Death and Differentiation|2005|48